Daxor EBITDA Margin 2010-2011 | DXR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Daxor (DXR) over the last 10 years. The current EBITDA margin for Daxor as of December 31, 2011 is .
| Daxor EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2011-12-31 | $0.00B | $-0.01B | 0.00% |
| 2011-09-30 | $0.00B | $-0.01B | 0.00% |
| 2011-06-30 | $0.00B | $-0.01B | 0.00% |
| 2011-03-31 | $0.00B | $-0.01B | 0.00% |
| 2010-12-31 | $0.00B | $0.00B | 0.00% |
| 2010-09-30 | $0.00B | $0.00B | 0.00% |
| 2010-06-30 | $0.00B | $0.00B | 0.00% |
| 2010-03-31 | $0.00B | $0.00B | 0.00% |
| 2009-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.052B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $20.544B | 19.63 |
| Encompass Health (EHC) | United States | $12.432B | 24.83 |
| DaVita (DVA) | United States | $9.837B | 14.07 |
| Elanco Animal Health (ELAN) | United States | $8.689B | 19.43 |
| Chemed (CHE) | United States | $6.617B | 22.16 |
| RadNet (RDNT) | United States | $5.277B | 190.58 |
| Option Care Health (OPCH) | United States | $4.518B | 19.33 |
| LifeStance Health (LFST) | United States | $2.139B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.102B | 22.66 |
| Astrana Health (ASTH) | United States | $1.680B | 58.76 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.471B | 27.08 |
| U.S Physical Therapy (USPH) | United States | $1.284B | 32.12 |
| Atai Life Sciences (ATAI) | Germany | $0.941B | 0.00 |
| Pennant (PNTG) | United States | $0.855B | 30.18 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.049B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |